FDA Inspection
United Exchange Corp.United Exchange Corp. – FDA Inspection, Apr 6, 2018
Record Details
This FDA Inspection record concerns United Exchange Corp., with an inspection on April 6, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · ccfb0f99-9f5c-4dd6-ae6b-aa274fcb58c5
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1047419
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.160(b)(3)Drug products - samples representative, identified properly
- 21 CFR 211.42(c)(7)Quarantined Drug Products Area
Full citation text and observation details available on the Dashboard.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.